Our results demonstrate that the platform has a high specificity for ACPA detection, especially taking into account that the control group consisted of patients affected by PsA, an inflammatory disease whose clinical presentation can simulate that of RA. The gene discussed is PRTN3; the disease is rheumatoid arthritis.